FAM201A encodes small protein NBASP to inhibit neuroblastoma progression via inactivating MAPK pathway mediated by FABP5

Commun Biol. 2023 Jul 12;6(1):714. doi: 10.1038/s42003-023-05092-7.

Abstract

Increasing evidence indicates that long non-coding RNA (lncRNA) is one of the most important RNA regulators in the pathogenesis of neuroblastoma (NB). Here, we found that FAM201A was low expressed in NB and a variety of gain and loss of function studies elucidated the anti-tumor effects of FAM201A on the regulation of proliferation, migration and invasion of NB cells. Intriguingly, we identified the ability of FAM201A to encode the tumor-suppressing protein, NBASP, which interacted with FABP5 and negatively regulated its expression. In vivo assays also revealed NBASP repressed NB growth via inactivating MAPK pathway mediated by FABP5. In conclusion, our findings demonstrated that NBASP encoded by FAM201A played a tumor-suppressor role in NB carcinogenesis via down-regulating FABP5 to inactivate the MAPK pathway. These results extended our understanding of the relationship of lncRNA-encoded functional peptides and plasticity of tumor progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Assay
  • Carcinogenesis
  • Fatty Acid-Binding Proteins* / genetics
  • Humans
  • Neoplasm Proteins
  • Neuroblastoma* / genetics
  • RNA, Long Noncoding* / genetics

Substances

  • FABP5 protein, human
  • Fatty Acid-Binding Proteins
  • Neoplasm Proteins
  • RNA, Long Noncoding
  • FAM201A long noncoding RNA, human